Serial 79230436
Live / Registered — Registered — partial invalidation of extension of protection (as of 14 Oct 2025)
What this means for you
Registered since 28 May 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79230436
- Registration number
- 5759811
- Mark type
- Design / logo
- Filed
- 18 Jan 2018
- Published for opposition
- 12 Feb 2019
- Registered
- 28 May 2019
- Attorney of record
- Geza C Ziegler Jr
Goods and services
- Class 005 — Pharmaceuticals: [ Pharmaceuticals for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders adapted for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical compositions for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders adapted for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical preparations for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical preparations for inhalers, namely, medical pharmaceutical compositions for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders structured for delivery into the body by nebulizer, aerosol, or dry powder, via the lungs or via the nasal passageway; Dietary supplements; Pharmaceutical products for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders ]
- Class 009 — Scientific and electric apparatus: Vials for scientific purposes being laboratory equipment; Vials for laboratory use; Glass tubes for scientific purposes being laboratory equipment, none of the aforesaid being additive manufacturing devices or 3D devices
- Class 010 — Medical apparatus: [ Surgical, medical, dental and veterinary apparatus and instruments, namely, injection devices for administering drugs sold empty; ] Medical apparatus for facilitating the inhalation of pharmaceutical preparations; [ Medical syringes sold empty for administering pharmaceuticals; ] Medical apparatus for introducing pharmaceutical preparations into the human body; Inhalers for medical use; Medical inhalers; [ Respiratory monitors for medical use; Apparatus for measuring lung function; Spirometers for examining the function of the lungs; Spirometers; Spirometer mouth pieces and tubing; breath gas analyzers for medical diagnostics; ] Replacement cartridges for medical inhalers sold empty; Nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of asthma and respiratory diseases
- Class 042 — Scientific and technological services: Scientific and technological services, namely, research and design in the field of drug delivery via the lungs or via the nasal passageway; Scientific and technological design of new products for others; Advisory services relating to design engineering; Advisory services relating to product testing; Product design and development in the field of drug delivery via the lungs or via the nasal passageway; New product design services, namely, analysis and evaluation of product design; engineering design and consultancy; Professional consultancy relating to medical technology; engineering project management services, not for business purposes; Engineering research; Pharmaceutical research and development services; research and development for the pharmaceutical industry; Research relating to medicines; none of the aforesaid in relation to additive manufacturing services or 3D printing services
- Class 044 — Medical, beauty and agricultural services: Pharmaceutical compounding services; Pharmaceutical compounding consultation services; Pharmaceutical compounding advisory services; Medical services [ ; Veterinary services; Hygienic and beauty care for animals; Hygienic and beauty care for humans ]
Owner
- Merxin Ltd, Norfolk, GB
- Merxin Ltd, GB
- Merxin Ltd, GB
Prosecution history
- 14 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 14 Oct 2025 — REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
- 13 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 03 Oct 2025 — POST REGISTRATION ACTION MAILED - SEC. 71 & 15
- 03 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 27 Aug 2025 — POST REGISTRATION ACTION MAILED - SEC. 71 & 15
- 25 Aug 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 May 2025 — TEAS SECTION 71 & 15 RECEIVED
- 16 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 May 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 16 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 16 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 May 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 16 May 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 16 Jun 2024 — NEW REPRESENTATIVE AT IB RECEIVED